Shares of Ocugen Inc. OCGN rallied 4.94% to $0.58 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.22% to 5,662.89 and Dow ...
After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will continue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback